Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Eating Disorders
What is your pharmacologic approach to binge eating disorder with patients where stimulant medications (i.e. lisdexamfetamine/Vyvanse) are contraindicated or ineffective?
Related Questions
What is your approach to GLP-1 agonists as a psychiatrist in patients who are overweight or have eating-related disorders?
When do you recommend neuropsychological testing in adults being evaluated for ADHD?
What pharmacologic and non-pharmacologic interventions have you found helpful in the treatment of misophonia?
How do you approach treatment-resistant depression and anxiety related to menopause refractory to SSRI/SNRIs and hormone replacement therapy?
How do you manage patients with severe, refractory schizophrenia or schizoaffective disorder who need complex pharmacologic regimens but consistently refuse labs and ECG monitoring?
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Is there a role for functional medicine approaches in psychiatric treatment?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What factors influence your decision to continue or taper antipsychotics for behavioral symptoms of dementia after the acute phase resolves?
How do you manage patients who develop SIADH secondary to an SSRI but have had a strong positive response to that same medication?
